Issue Title
Vol 22, No 1 (2020) Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
Abstract PDF
(Rus)
Kolyadina I.V., Danzanova T.Y., Khokhlova S.V., Trofimova O.P., Kovaleva E.V., Rodionov V.V., Poddubnaya I.V.
Vol 17, No 1 (2015) A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian
Abstract
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
Vol 16, No 3 (2014) Avastin in clinical chemotherapy of malignant tumors
Abstract
Gorbunova V.A.
Vol 21, No 3 (2019) Complex radiologic imaging of early breast cancer (literature review)
Abstract PDF
(Rus)
Aliyeva G.S., Korzhenkova G.P., Kolyadina I.V.
Vol 17, No 1 (2015) Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience)
Abstract
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Frank G.A., Komov D.V., Karseladze A.I., Bastiaannet E., Dekker-Ensink N.G.
Vol 22, No 1 (2020) The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study
Abstract PDF
(Rus)
Kovalenko E.I., Artamonova E.V., Karabina E.V., Andreiashkina I.I., Prokof’eva E.A., Popova N.O., Gaisina E.A., Evstigneeva I.V., Shaidorov M.V., Zhiliaeva L.A., Ponomarenko D.M., Khasanova A.I., Mukhametshina G.Z., Koziakov A.E., Vorotilina L.V., Povyshev A.I., Simolina E.I., Marfutov V.V., Kozlov D.V., Suslova I.R., Shikina V.E., Karandeeva T.V., Shepel’ A.O., Kramskaia L.V., Oskirko D.A., Frolova O.S.
Vol 18, No 1 (2016) Rare morphological forms of breast cancer: features of surgical approach
Abstract PDF
(Rus)
Vysotskaya I.V., Letyagin V.P., Kolyadina I.V., Martynova G.V.
Vol 20, No 3 (2018) The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Abstract PDF
(Rus)
Kolyadina I.V., Poddubnaya I.V.
Vol 20, No 2 (2018) The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Abstract PDF
(Rus)
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
Vol 15, No 2 (2013) Prognostic value of p53 expression in patients with stage I breast cancer
Abstract
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Liefers G.J., Dekker-Ensink N.G., Bastiaannet E., Van As-Sajet A., Prinse B., Engels C., Van Vlierberghe R., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V., Frank G.A., Banov S.M.
Vol 21, No 3 (2019) The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
Abstract PDF
(Rus)
Gordeeva O.O., Kolyadina I.V., Zhukova L.G., Gan'shina I.P., Komov D.V., Meshcheriakov A.A.
Vol 19, No 1 (2017) Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
Abstract PDF
(Rus)
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
Vol 21, No 3 (2019) The predictive value of digital mammography, breast ultrasound and their combination in the diagnosis of early breast cancer
Abstract PDF
(Rus)
Alieva G.S., Korzhenkova G.T., Kolyadina I.V.
Vol 21, No 1 (2019) The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
Abstract PDF
(Rus)
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I.
Vol 19, No 2 (2017) PARP inhibitors in female reproductive system cancers
Abstract PDF
(Rus)
Pokataev I.A., Tyulyandin S.A.
Vol 17, No 1 (2015) The use of combined plastic interventions in the reconstruction of post-operative soft tissue defects of the chest wall in the surgical treatment of locally advanced breast cancer
Abstract
Vashenko L.N., Daschkova I.R., Bakulina S.M., Andreyko E.A.
Vol 18, No 2 (2016) Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Abstract PDF
(Rus)
Karabina E.V., Zhukova L.G.
Vol 18, No 2 (2016) New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Abstract PDF
(Rus)
Semiglazova T.Y., Klyuge V.A., Semiglazov V.V., Teletaeva G.M., Krivorotko P.V., Dashyan G.A., Paltuev R.M., Tkachenko E.V., Donskikh R.V., Semiglazov V.F.
Vol 20, No 1 (2018) Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
Abstract PDF
(Rus)
Kolbin A.S., Mosikyan A.A., Balykina Y.E., Proskurin M.A.
Vol 16, No 2 (2014) High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)
Abstract
Seryakov A.P., Ovchinnikova L.K., Zabelin M.V., Yakubov T.Z., Sidorov D.B., Ovchinnikov M.V.
Vol 19, No 1 (2017) Albumin-bound paclitaxel in the treatment of metastatic breast cancer
Abstract PDF
(Rus)
Artamonova E.V.
Vol 18, No 1 (2016) Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy
Abstract PDF
(Rus)
Kolyadina I.V., Poddubnaya I.V., Pavlikova O.A., Komov D.V.
Vol 20, No 1 (2018) The effect of derivatives of 3-hydroxypyridine and succinic acids on depressive symptoms, pain intensity and quality of life after surgical treatment of breast cancer
Abstract PDF
(Rus)
Volchegorskii I.A., Vazhenin A.V., Zyuzina M.S.
Vol 16, No 3 (2014) Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women
Abstract
Jackisch C., Llombart-Cussac A.
Vol 21, No 1 (2019) Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports
Abstract PDF
(Rus)
Savelyeva M.I., Dudina I.A., Zaharenkova J.S., Ignatova A.K., Ryzhikova K.A., Sozaeva Z.A., Kudlay D.A., Perfileva O.M., Poddubnaya I.V.
Vol 20, No 1 (2018) Dermatomyositis and polymyositis in breast cancer patients: a case reports
Abstract PDF
(Rus)
Ganshina I.P., Zhukova L.G., Burnevitch E.Z., Gordeeva O.O., Kondratieva O.E.
Vol 17, No 1 (2015) Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Abstract
Semiglazova T.Y., Dashyan G.A., Semiglazov V.V., Zhabina A.S., Osipov M.A., Kotova Z.S., Klimenko V.V., Krivorotko P.V., Semiglazov V.F.
Vol 16, No 2 (2014) The results of Epidemiological HER2 screening program in patients with breast cancer in 2013
Abstract
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A., Koroleva N.I.
Vol 18, No 3 (2016) Circulating tumor cell: biology, methods of isolation, clinical significance in breast cancer
Abstract PDF
(Rus)
Nenahova Y.N., Lyadov V.K., Poddubnaya I.V.
Vol 21, No 1 (2019) Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
Abstract PDF
(Rus)
Gorbunova V.A., Kolyadina I.V., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Filonenko D.V., Zhilyaeva L.A., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Suslova I.R., Romanchuk O.V., Kozlov D.V., Rzaev A.S., Marfutov V.V., Andreiashkina I.I., Vladimirova L.I., Mitashok I.S., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Morozov D.A., Prokof'eva E.P., Kramskaia L.V., Karandeeva T.V., Evstigneeva I.V., Ovchinnikova E.G., Klement'eva T.P., Khrupalo O.V., Tiuvinova E.V., Sherstnev V.M., Chernov I.S., Kolokolov D.D., Gaisina E.A., Levchenko N.V., Chubenko V.A., Povyshev A.I., Iudina I.V., Vorotilina L.V., Andreeva T.V., Tumanian G.S., Koziakov A.E., Gil'mutdinova L.A., Osipov M.A., Shatokhina A.S., Vazhenina A.A., Chichkanova A.S., Vladimirov V.I., Ivanov A.N., Belokhvostova A.S., Cherniakova E.M., Tul'china E.A., Maklashova S.A., Shkodenko O.N., Kostalanova I.V., Tarasova A.V., Kuz'mina E.S.
Vol 17, No 3 (2015) The results of Epidemiological HER2 screening program in patients with breast cancer in 2014
Abstract
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
Vol 19, No 4 (2017) Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case
Abstract PDF
(Rus)
Kolyadina I.V., Ganshina I.P., Zhukova L.G., Abdullaev A.G., Andreeva Y.Y., Danzanova T.Y., Sinyukova G.T., Komov D.V., Kozlov N.A., Filonenko D.A., Gordeeva O.O., Lubennikova E.V.
Vol 17, No 1 (2015) Breast cancer immunology: theory and prospects (review)
Abstract
Kolyadina I.V., Poddubnaya I.V.
Vol 16, No 2 (2014) Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Abstract
Artamonova E.V., Gorbunova V.A., Zhukov N.V., Manzjuk L.V., Manihas A.G., Paltuev P.M., Semiglazov V.F., Semiglazova T.Y., Stenina M.B., Tjuljandin S.A., Chubenko V.A.
Vol 18, No 4 (2016) Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer
Abstract
Vladimirova L.Y.
Vol 21, No 2 (2019) The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
Abstract PDF
(Rus)
Kolyadina I.V., Bulavina I.S., Petkau V.V., Strakhova N.V., Gorbunova V.A., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Gan'shina I.P., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Khokhlova S.V., Filonenko D.V., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Vladimirova L.I., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Orlov A.E., Kostalanova I.V., Levchenko N.V., Osipov M.A., Karandeeva T.V., Evstigneeva I.V., Chernov I.S., Kolokolov D.D., Povyshev A.I., Shatokhina A.S., Cherniakova E.M., Shkodenko O.N., Kuz'mina E.S.
Vol 17, No 4 (2015) Neoadjuvant systemic therapy of HER2-positive breast cancer
Abstract
Frolova M.A.
Vol 19, No 4 (2017) Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0
Abstract PDF
(Rus)
Pavlikova O.A., Poddubnaya I.V., Kolyadina I.V., Abdullaev A.G., Komov D.V., Danzanova T.Y., Sinyukova G.T., Kozlov N.A., Ganshina I.P., Zhukova L.G., Aliyeva G.S., Kerimov R.A., Gordeeva O.O.
Vol 16, No 4 (2014) Male breast cancer: review of the literature
Abstract
Nikolaev K.S., Semiglazov V.F., Semiglazov V.V.
Vol 16, No 1 (2014) New chemotherapy options for triple-negative breast cancer (review of literature)
Abstract
Sekundova M.A., Zdvizhkov A.M., Borisov V.I.
Vol 18, No 2 (2016) Cost-effectiveness of empegfilgrastim (Extimia®) for the prevention of severe neutropenia in patients with malignant neoplasm of female breast
Abstract PDF
(Rus)
Rudakova A.V., Tolkacheva D.G., Gavrilova O.N., Vaganov A.S.
Vol 17, No 2 (2015) Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Abstract
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A.
Vol 19, No 3 (2017) Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Abstract PDF
(Rus)
Artamonova E.V.
Vol 16, No 4 (2014) Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I?
Abstract
Kolyadina I.V., Poddubnaya I.V., Trofimova O.P., Frank G.A., Karseladze A.I., Komov D.V.
Vol 15, No 4 (2013) Bone mineral density in patient with breast cancer
Abstract
Poddubnaya I.V., Kizhaev E.V., Kolyadina I.V., Banov S.M., Zhmaeva E.M., Secko M.A.
Vol 18, No 3 (2016) The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer
Abstract PDF
(Rus)
Frolova M.A.
Vol 20, No 2 (2018) The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)
Abstract PDF
(Rus)
Stepanova A.M., Merzlyakova A.M., Khulamhanova M.M., Trofimova O.P.
Vol 17, No 2 (2015) Stereotactic biopsy of breast lesions under x-ray control
Abstract
Manikhas G.M., Safronova O.B., Khudjakova T.G., Barabanova L.P., Punanova N.J.
Vol 19, No 2 (2017) Perspectives of pharmacogenetics approach to personalized tamoxifen therapy
Abstract PDF
(Rus)
Savelyeva M.I., Ignatova A.K., Panchenko Y.S., Urvantseva I.A., Poddubnaya I.V.
Vol 15, No 4 (2013) The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Abstract
Semiglazov V.F., Semiglazov V.V., Paltuev P.M., Nikolaev K.S., Dashyan G.A.
Vol 18, No 2 (2016) Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study
Abstract PDF
(Rus)
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
Vol 17, No 2 (2015) Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy
Abstract
Artamonova E.V., Manziuk L.V.
Vol 19, No 2 (2017) Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary?
Abstract PDF
(Rus)
Trigolosov A.V., Uimanov V.A., Chernikh M.V., Petrovskiy A.V., Nikitina E.A., Nechushkin M.I.
Vol 16, No 4 (2014) Modern possibilities of HER2 positive breast cancer treatment (based on clinical trials)
Abstract
Kolyadina I.V., Poddubnaya I.V.
Vol 18, No 3 (2016) The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia
Abstract PDF
(Rus)
Bolotina L.V., Manziuk L.V., Gorbunova V.A., Kovalenko E.I., Mukhametshina G.Z., Khasanova A.I., Vladimirova L.Y., Mitashok I.S., Prokofyeva E.P., Evstigneeva I.V., Andreyashkina I.I., Abramova N.A., Popova I.L., Karabina E.V., Teterich A.A., Gaysina E.A., Chubenko V.A., Limareva S.V., Tikhanovskaya N.M., Storozhakova A.E., Samaneva N.Y., Svetitskaya Y.V., Snezhko T.A., Kalabanova E.A.
Vol 20, No 2 (2018) Ribociclib in 1st line HR+ breast cancer treatment
Abstract PDF
(Rus)
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V.
Vol 17, No 2 (2015) The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients
Abstract
Frank G.A., Ilatovskaia M.E., Andreeva I.I., Zavalishina L.E.
Vol 16, No 3 (2014) Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial
Abstract
Ahmetzanov F.S., Ahmetzanova F.F.
Vol 15, No 2 (2013) New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
Abstract
Artamonova E.V., Manzyuk L.V.
Vol 18, No 3 (2016) The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015
Abstract PDF
(Rus)
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
Vol 20, No 2 (2018) Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Abstract PDF
(Rus)
Frolova M.A., Kochetkova Y.I., Chubenko V.A., Volkov N.M., Moiseenko F.V., Garmarnik T.V., Ponomarenko D.M., Orlov A.E., Kostalanova Y.V., Makarycheva Y.Y., Nizegorodzeva A.A.
Vol 19, No 1 (2017) Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
Abstract PDF
(Rus)
Kolbin A.S., Mosikyan A.A., Kurilev A.A., Balykina Y.E., Proskurin M.A.
Vol 15, No 1 (2013) Current approach to adjuvant therapy for breast cancer (a review)
Abstract
Conte P., Guarneri V.
Vol 21, No 3 (2019) Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population
Abstract PDF
(Rus)
Grechukhina K.S., Zhukova L.G.
Vol 20, No 2 (2018) Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?
Abstract PDF
(Rus)
Zhukova L.G., Ganshina I.P., Khatkova E.I., Tikhomirova T.E., Kondratyeva O.E.
Vol 17, No 1 (2015) Radiation-induced lung injury in breast cancer patients after breast conservation therapy
Abstract
Trofimova O.P., Tkachev S.I., Ivanov S.M., Utkina V.L., Cheban O.I., Glebovskaya V.V.
Vol 16, No 3 (2014) Personalized approach to HER2-positive advanced breast cancertherapy
Abstract
Stenina M.B.
1 - 67 of 67 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies